Actively Recruiting
Kangaroo Care: Breastfeeding Success and Maternal Role
Led by Recep Tayyip Erdogan University · Updated on 2026-04-28
112
Participants Needed
1
Research Sites
82 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Purpose: This is a randomized controlled trial designed to investigate the effects of Kangaroo Mother Care (KMC) applied in the early postpartum period to primiparous mothers on breastfeeding success and the perception of the maternal role. Methodology and Sample: Setting and Period: The study will be conducted at the Bucak State Hospital Delivery Unit between June 2025 and June 2026. Sample Size: Based on G\*Power analysis (alpha=0.05, power=80%, effect size d=0.566), a total of 112 mothers (56 intervention, 56 control) will be included, accounting for a 10% potential attrition rate. Participants will be assigned to groups using the sealed envelope method and randomization via www.random.org. Intervention: Experimental Group: Following routine care, the newborn will be placed in a "chest-to-chest" position on the mother's bare chest for Kangaroo Care. Intermittent KMC will be maintained for 24 hours, during which breastfeeding attempts will be supported. Control Group: Mothers and newborns will receive only the hospital's routine care (standard skin-to-skin contact and breastfeeding support). Data Collection Tools: Personal Information Form, Semantic Differential Scale-Myself as a Mother (to measure maternal role perception), LATCH Breastfeeding Assessment Tool (to evaluate breastfeeding success).
CONDITIONS
Official Title
Kangaroo Care: Breastfeeding Success and Maternal Role
Who Can Participate
Eligibility Criteria
You may qualify if you...
-
For mothers:
- It must be the mother's first birth,
- Birth must have been vaginal,
- The mother must be healthy,
- The mother must voluntarily participate in the study,
- The mother must not have any communication-impairing conditions (language, cognitive problems, etc.),
For babies:
- Birth weight must be between 2500-4000 grams;
- The newborn must be healthy,
- Exclusively breastfed,
- The newborn must be at term gestation (38-42 weeks),
- The newborn's Apgar score at 1 and 5 minutes must be above 7,
- The newborn must not have any health problems that could affect breastfeeding (cleft palate, cleft lip, esophageal atresia, etc.).
You will not qualify if you...
-
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Bucak State Hospital
Rize, Turkey (Türkiye)
Actively Recruiting
Research Team
G
Gamzegül ALTAY, Assistant Professor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here